Wells Fargo’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1
| Closed | -$10 | – | 6549 |
|
|
2024
Q3 | $10 | Hold |
1
| – | – | ﹤0.01% | 6252 |
|
|
2024
Q2 | $12 | Sell |
1
-7
| -88% | -$84 | ﹤0.01% | 6221 |
|
|
2024
Q1 | $175 | Hold |
8
| – | – | ﹤0.01% | 6131 |
|
|
2023
Q4 | $73 | Buy |
8
+3
| +60% | +$27 | ﹤0.01% | 6400 |
|
|
2023
Q3 | $150 | Buy |
5
+4
| +400% | +$120 | ﹤0.01% | 6275 |
|
|
2023
Q2 | $57 | Hold |
1
| – | – | ﹤0.01% | 6716 |
|
|
2023
Q1 | $277 | Hold |
1
| – | – | ﹤0.01% | 6366 |
|
|
2022
Q4 | $660 | Hold |
1
| – | – | ﹤0.01% | 5980 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6308 |
|
|
2022
Q2 | $0 | Sell |
1
-4
| -80% | – | ﹤0.01% | 6480 |
|
|
2022
Q1 | $11K | Sell |
5
-10
| -67% | -$22K | ﹤0.01% | 5875 |
|
|
2021
Q4 | $72K | Buy |
+15
| New | +$72K | ﹤0.01% | 5364 |
|
|
2021
Q3 | – | Sell |
-6
| Closed | -$62K | – | 6215 |
|
|
2021
Q2 | $62K | Sell |
6
-4
| -40% | -$41.3K | ﹤0.01% | 5159 |
|
|
2021
Q1 | $84K | Sell |
10
-5
| -33% | -$42K | ﹤0.01% | 5219 |
|
|
2020
Q4 | $114K | Hold |
15
| – | – | ﹤0.01% | 5150 |
|
|
2020
Q3 | $98K | Buy |
15
+6
| +67% | +$39.2K | ﹤0.01% | 5078 |
|
|
2020
Q2 | $67K | Sell |
9
-3
| -25% | -$22.3K | ﹤0.01% | 5150 |
|
|
2020
Q1 | $87K | Hold |
12
| – | – | ﹤0.01% | 4929 |
|
|
2019
Q4 | $193K | Hold |
12
| – | – | ﹤0.01% | 4811 |
|
|
2019
Q3 | $118K | Sell |
12
-42
| -78% | -$413K | ﹤0.01% | 5015 |
|
|
2019
Q2 | $853K | Buy |
+54
| New | +$853K | ﹤0.01% | 3897 |
|